)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Interpace Biosciences (IDXG) investor relations material
Interpace Biosciences Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary7 Aug, 2025
Executive summary
Q2 2025 revenue declined 23% year-over-year to $9.2M, mainly due to PancraGEN® Medicare coverage loss; net loss was $0.6M compared to net income of $2.4M in Q2 2024.
Six-month revenue fell 7% year-over-year to $20.7M; net income for the period was $1.0M, down from $3.1M in the prior year.
Record thyroid test volume and revenue, with thyroid revenue up 25% year-over-year to $8.7M, offsetting some PancraGEN® impact.
Loss from continuing operations was $0.5M, including $1.2M in one-time charges related to PancraGEN® wind-down.
Restructuring plan implemented in response to PancraGEN® loss, resulting in $0.7M in severance and related costs in H1 2025.
Financial highlights
Gross margin for Q2 2025 was 57%, down from 65% in Q2 2024; six-month gross margin was 61%, down from 64%.
Operating loss from continuing operations in Q2 2025 was $0.5M, compared to operating income of $2.6M in Q2 2024.
Adjusted EBITDA for Q2 2025 was $0.4M, down from $2.8M in Q2 2024; for the six months, Adjusted EBITDA was $2.5M, down from $4.0M.
Cash and cash equivalents as of June 30, 2025 were $0.5M; current assets totaled $9.5M, current liabilities $7.1M.
Net cash provided by operating activities for H1 2025 was $1.8M; cash used in financing activities was $2.5M, mainly for loan repayments.
Outlook and guidance
Management anticipates current cash and forecasted receipts will be sufficient for the next twelve months despite PancraGEN® loss.
Positive trends in thyroid testing and revenue growth are expected to continue into Q3 and beyond, with July 2025 revenue preliminary results up 54% year-over-year.
The company is exploring strategic alternatives and funding options due to capital constraints and delisting from Nasdaq.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Interpace Biosciences earnings date
Q3 20253 Nov, 2025
Next Interpace Biosciences earnings date
Q3 20253 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Interpace Biosciences, Inc. is a U.S.-based company specializing in molecular diagnostic tests and pathology services. The company provides diagnostic solutions for detecting, monitoring, and managing risks related to cancer, particularly in areas such as thyroid, gastrointestinal, and lung cancers. Interpace Biosciences serves healthcare providers, patients, and pharmaceutical companies by offering personalized diagnostic information to guide clinical decision-making. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the OTCQB.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage